| Clinical outcomes and salvage therapies in patients with relapsed/refractory multiple myeloma following progression on BCMA-targeted CAR-T therapy KR Reyes, YC Liu, CY Huang, R Banerjee, T Martin, N Shah, SW Wong, ... Blood 140 (Supplement 1), 617-619, 2022 | 10 | 2022 |
| Salvage therapies including retreatment with BCMA-directed approaches after BCMA CAR-T relapses for multiple myeloma KR Reyes, YC Liu, CY Huang, R Banerjee, T Martin, SW Wong, JL Wolf, ... Blood Advances 8 (9), 2207-2216, 2024 | 4 | 2024 |
| Semiparametric estimation of the transformation model by leveraging external aggregate data in the presence of population heterogeneity YJ Cheng, YC Liu, CY Tsai, CY Huang Biometrics 79 (3), 1996-2009, 2023 | 2 | 2023 |
| Salvage therapies and clinical outcomes after relapse following BCMA CAR-T in patients with relapsed/refractory multiple myeloma K Reyes, YC Liu, CY Huang, R Banerjee, T Martin, N Shah, S Wong, ... CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 22, S31-S32, 2022 | 2 | 2022 |
| Discussion of “Some statistical challenges in automated driving systems” D Banks, YC Liu Applied Stochastic Models in Business and Industry 39 (5), 653-656, 2023 | | 2023 |
| OAB-051: Salvage therapies and clinical outcomes after relapse following BCMA CAR-T in patients with relapsed/refractory multiple myeloma K Reyes, YC Liu, CY Huang, R Banerjee, T Martin, N Shah, S Wong, ... Clinical Lymphoma Myeloma and Leukemia 22, S31-S32, 2022 | | 2022 |
